by Josh Forsythe, on January 7, 2016
This financing will enable PierianDx to expand its lead as a pioneer in Next Generation Sequencing (NGS) software and services. PierianDx will use the funding to accelerate product development and …
Check back regularly for engaging perspectives on clinical genomics.
77 Maryland PlazaSt. Louis, Missouri 63108